Antiretroviral Naive

Also known as: Antiretroviral-naïve / Antiretroviral Treatment-Naïve / Antiretroviral treatment naive

Drug	Drug Name	Drug Description
DB11799	Bictegravir	An integrase inhibitor used to treat HIV infections.
DB12301	Doravirine	A non-nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals to treat HIV-1 infections.

Drug	Drug Name	Target	Type
DB11799	Bictegravir	Reverse transcriptase/RNaseH	target
DB11799	Bictegravir	Integrase	target
DB11799	Bictegravir	Cytochrome P450 3A4	enzyme
DB11799	Bictegravir	UDP-glucuronosyltransferase 1-1	enzyme
DB11799	Bictegravir	POU domain, class 2, transcription factor 2	enzyme
DB11799	Bictegravir	Multidrug and toxin extrusion protein 1	enzyme
DB12301	Doravirine	Cytochrome P450 3A4	enzyme
DB12301	Doravirine	Cytochrome P450 3A5	enzyme
DB12301	Doravirine	Reverse transcriptase/RNaseH	target

Drug	Drug Name	Phase	Status	Count
DB00900	Didanosine	2	Completed	1
DB00625	Efavirenz	2	Completed	1
DB00879	Emtricitabine	2	Completed	1